A new device in the treatment of glaucoma has been introduced by Opthalmic Sciences. IOPerfect works by using artificial intelligence (AI) in a virtual reality-type headset which allows telediagnosis and remote monitoring.
It can be self-administered, and patients can wear the headset to monitor their IOP (fluid pressure inside the eyes) at home. It is non-invasive and without the need for eye...
Swiss healthtech focused private equity firm, MTIP has announced the closing of its MTIP Fund II at $250 million (€221m) in capital commitments.
The oversubscribed fund, which closed above its target of $225 million (€199m), continues its predecessor fund’s strategy of investing in growing and innovative healthtech companies primarily across Europe.
MTIP Fund II is a designated ‘dark green’ fund...
Oncology startup Vinehealth has announced a raise of $5.5 million (€ 4.9m) in seed funding.
The round was led by Talis Capital, with participation from previous investors Playfair Capital and Ascension. A number of angels also participated.
WHAT IT DOES
Founded in 2018 by Rayna Patel and Georgina Kirby, Vinehealth is a digital health platform that aims to improve the quality of life and...
Digital health firm Babylon has launched its artificial intelligence (AI) powered triage tool in Rwanda to further digitise the Rwandan healthcare system.
Babylon, known locally as Babyl, has been delivering digital health services in Rwanda since 2016 and, last year, embarked on a 10-year partnership with the Government of Rwanda to build Africa’s first digital-first universal healthcare system...
The Portuguese startup company knok wants to break into the EU market with a telemedicine platform – and has received €4.4 million from the NOS 5G Fund.
As EU-Startups reported, the healthtech enterprise will invest the fund into further development of its 5G-enabled telehealth solutions.
WHY IT MATTERS
Founded in Porto in 2015, the company’s innovative telemedicine platform is based on the new...
Charité-University Medicine Berlin has established a new research partnership with the global data science company Holmusk. The strategic collaboration is focused on the collection and analysis of real-world data from psychiatry.
As Holmusk declared on 22 November, the initiative aims to improve the understanding of psychiatric diseases through evidence-based analytics.
WHY IT MATTERS
The COVID-...
The partnership will help visitors to Bayer websites for Aspirin, Aleve, Midol, Cenesten and Iberogast to access Ada’s intelligent symptom assessment platform.
Using an AI-based health assessment platform, Berlin-based Ada Health assists users in identifying the correct care, based on their individual requirements, risk factors and symptoms.
The free app provides guidance via an AI chatbot which...
Dublin-based medical adherence firm HealthBeacon to go public
Irish medtech firm HealthBeacon has announced plans to raise up to €25 million with an initial public offering (IPO) on Euronext Dublin’s growth market.
The company, which offers adherence solutions for injectable medications, will have a market value of around €100 million at the time of its planned flotation next month.
It expects...
The world’s largest online healthcare marketplace, Docplanner is investing significant capital and resources into new acquisition Jameda.
As part of the deal, Docplanner will add more than 200 new team members to Jameda, investing more than a quarter of a billion euros in the German market over the next three years.
Munich-based Jameda, Germany’s biggest online healthcare marketplace from Hubert...
The European Council has given the green light to a new, harmonised regulation on health technology assessments across EU member states.
Under the EU Health Technology Assessment (HTA) joint clinical assessments and joint scientific consultations on health technologies will be enabled between EU member states, to allow for more rapid assessments of healthcare technologies.
Key information will be...
_4_0.jpeg?itok=t4ZJ33Zu "Real-world data platform could enable large German mental health studies on a ‘Scandinavian scale’.")
